These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33592910)

  • 1. Association of non-alcoholic fatty liver disease and all-cause mortality in hospitalized cardiovascular disease patients: A systematic review and meta-analysis.
    Saokaew S; Kanchanasurakit S; Thawichai K; Duangprom P; Wannasri M; Khankham S; Kositamongkol C; Chaiyakunapruk N; Phisalprapa P
    Medicine (Baltimore); 2021 Feb; 100(5):e24557. PubMed ID: 33592910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis.
    Zhou YY; Zhou XD; Wu SJ; Hu XQ; Tang B; Poucke SV; Pan XY; Wu WJ; Gu XM; Fu SW; Zheng MH
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):631-636. PubMed ID: 29351115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.
    Mantovani A; Csermely A; Petracca G; Beatrice G; Corey KE; Simon TG; Byrne CD; Targher G
    Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):903-913. PubMed ID: 34555346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta-analysis with bias analysis.
    Morrison AE; Zaccardi F; Khunti K; Davies MJ
    Liver Int; 2019 Mar; 39(3):557-567. PubMed ID: 30358050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
    Jarvis H; Craig D; Barker R; Spiers G; Stow D; Anstee QM; Hanratty B
    PLoS Med; 2020 Apr; 17(4):e1003100. PubMed ID: 32353039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission.
    Wild SH; Walker JJ; Morling JR; McAllister DA; Colhoun HM; Farran B; McGurnaghan S; McCrimmon R; Read SH; Sattar N; Byrne CD;
    Diabetes Care; 2018 Feb; 41(2):341-347. PubMed ID: 29167212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease.
    Chinnadurai R; Chrysochou C; Kalra PA
    Nephron; 2019; 141(1):24-30. PubMed ID: 30384370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in mortality and liver-related events in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Zhou H; Chen H; Lu H; Wu B; Zhang S; Gu Y; Zhou G; Xiang J; Yang J
    Liver Int; 2024 Jul; 44(7):1600-1609. PubMed ID: 38506430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.
    Targher G; Byrne CD; Lonardo A; Zoppini G; Barbui C
    J Hepatol; 2016 Sep; 65(3):589-600. PubMed ID: 27212244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: A comprehensive systematic review and meta-analysis.
    Singh A; Hussain S; Antony B
    Diabetes Metab Syndr; 2021; 15(3):813-822. PubMed ID: 33862417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between non-alcoholic fatty liver disease and coronary artery disease outcomes: A systematic review and meta-analysis.
    Abosheaishaa H; Hussein M; Ghallab M; Abdelhamid M; Balassiano N; Ahammed MR; Baig MA; Khan J; Elshair M; Soliman MY; Abdelwahed M; Ali A; Alzamzamy A; Nassar M
    Diabetes Metab Syndr; 2024 Jan; 18(1):102938. PubMed ID: 38194827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality and Liver-Related Events in Lean Versus Non-Lean Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Ha J; Yim SY; Karagozian R
    Clin Gastroenterol Hepatol; 2023 Sep; 21(10):2496-2507.e5. PubMed ID: 36442727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes.
    Mantovani A; Mingolla L; Rigolon R; Pichiri I; Cavalieri V; Zoppini G; Lippi G; Bonora E; Targher G
    Int J Cardiol; 2016 Dec; 225():387-391. PubMed ID: 27768965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis.
    Wongtrakul W; Charatcharoenwitthaya N; Charatcharoenwitthaya P
    Ann Hepatol; 2024; 29(3):101288. PubMed ID: 38278181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis.
    Wu S; Wu F; Ding Y; Hou J; Bi J; Zhang Z
    Sci Rep; 2016 Sep; 6():33386. PubMed ID: 27633274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study.
    Kim JH; Moon JS; Byun SJ; Lee JH; Kang DR; Sung KC; Kim JY; Huh JH
    Cardiovasc Diabetol; 2020 May; 19(1):51. PubMed ID: 32359355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Bisaccia G; Ricci F; Khanji MY; Sorella A; Melchiorre E; Iannetti G; Galanti K; Mantini C; Pizzi AD; Tana C; Renda G; Fedorowski A; De Caterina R; Gallina S
    Curr Probl Cardiol; 2023 Jun; 48(6):101643. PubMed ID: 36773944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis.
    Liu Y; Zhong GC; Tan HY; Hao FB; Hu JJ
    Sci Rep; 2019 Jul; 9(1):11124. PubMed ID: 31366982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.